Evidence map›Paper›PMID 38997568›Full record

ArticleLa Radiologia medica2024

Prediction of microvascular invasion in hepatocellular carcinoma patients with MRI radiomics based on susceptibility weighted imaging and T2-weighted imaging.

Zhijun Geng, Shutong Wang, Lidi Ma, Cheng Zhang, Zeyu Guan, Yunfei Zhang, Shaohan Yin, Shanshan Lian, Chuanmiao Xie

Abstract read
PubMed Publisher
In one paragraph

Article in La Radiologia medica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. [Application of nanomaterials-enhanced magnetic resonance imaging in precise diagnosis of pan-vascular diseases].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zhijun Geng *Department of Radiology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in Southern China, No. 651 Dongfeng East Road, Guangzhou, 510060, People's Republic of China.
Shutong Wang *Department of Hepatic Surgery, First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, People's Republic of China.
Lidi Ma *Department of Radiology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in Southern China, No. 651 Dongfeng East Road, Guangzhou, 510060, People's Republic of China.
Cheng ZhangDepartment of Radiology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in Southern China, No. 651 Dongfeng East Road, Guangzhou, 510060, People's Republic of China.
Zeyu GuanMacau University of Science and Technology, Avenida Wai Long, Taipa, Macau, China.
Yunfei ZhangUnited Imaging Healthcare Co., Ltd, Shanghai, 201807, China.
Shaohan YinDepartment of Radiology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in Southern China, No. 651 Dongfeng East Road, Guangzhou, 510060, People's Republic of China.
Shanshan LianDepartment of Radiology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in Southern China, No. 651 Dongfeng East Road, Guangzhou, 510060, People's Republic of China.
Chuanmiao XieDepartment of Radiology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in Southern China, No. 651 Dongfeng East Road, Guangzhou, 510060, People's Republic of China. xchuanm@sysucc.org.cn.ORCID http://orcid.org/0009-0002-8543-7676

Funding

Medical Science and Technology Foundation of Guangdong Province C2022061
6 · The paper itself

Abstract

backgroundThe accurate identification of microvascular invasion (MVI) in patients with hepatocellular carcinoma (HCC) is of great clinical importance. PURPOSE: To develop a radiomics nomogram based on susceptibility-weighted imaging (SWI) and T2-weighted imaging (T2WI) for predicting MVI in early-stage (Barcelona Clinic Liver Cancer stages 0 and A) HCC patients. MATERIALS AND

methodsA prospective cohort of 189 participants with HCC was included for model training and testing, and an additional 34 participants were enrolled for external validation. ITK-SNAP was used to manually segment the tumour, and PyRadiomics was used to extract radiomic features from the SWI and T2W images. Variance filtering, student's t test, least absolute shrinkage and selection operator regression and random forest (RF) were applied to select meaningful features. Four machine learning classifiers, including K-nearest neighbour, RF, logistic regression and support vector machine-based models, were established. Independent clinical and radiological risk factors were also determined to establish a clinical model. The best radiomics and clinical models were further evaluated in the validation set. In addition, a nomogram was constructed from the radiomic model and independent clinical factors. Diagnostic efficacy was evaluated by receiver operating characteristic curve analysis with fivefold cross-validation.

resultsAFP levels greater than 400 ng/mL [odds ratio (OR) 2.50; 95% confidence interval (CI) 1.239-5.047], tumour diameter greater than 5 cm (OR 2.39; 95% CI 1.178-4.839), and absence of pseudocapsule (OR 2.053; 95% CI 1.007-4.202) were found to be independent risk factors for MVI. The areas under the curve (AUCs) of the best radiomic model were 1.000 and 0.882 in the training and testing cohorts, respectively, while those of the clinical model were 0.688 and 0.6691. In the validation set, the radiomic model achieved better diagnostic performance (AUC = 0.888) than the clinical model (AUC = 0.602). The combination of clinical factors and the radiomic model yielded a nomogram with the best diagnostic performance (AUC = 0.948).

conclusionSWI and T2WI-derived radiomic features are valuable for noninvasively and accurately identifying MVI in early-stage HCC. Furthermore, the integration of radiomics and clinical factors yielded a predictive nomogram with satisfactory diagnostic performance and potential clinical benefits.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsMagnetic Resonance ImagingMicrovesselsNeoplasm InvasivenessNomogramsAdultAgedFemaleHumansMaleMiddle AgedPredictive Value of TestsProspective StudiesRadiomicsHepatocellular carcinomaMicrovascular invasionRadiomicsSusceptibility-weighted imaging (SWI)T2-weighted imaging (T2WI)

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.